nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A4—type 2 diabetes mellitus	0.194	1	CbGaD
Oxybutynin—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0501	0.0983	CbGbCtD
Oxybutynin—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0401	0.0786	CbGbCtD
Oxybutynin—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0363	0.0711	CbGbCtD
Oxybutynin—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0335	0.0656	CbGbCtD
Oxybutynin—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0323	0.0633	CbGbCtD
Oxybutynin—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0286	0.056	CbGbCtD
Oxybutynin—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0263	0.0516	CbGbCtD
Oxybutynin—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0231	0.0453	CbGbCtD
Oxybutynin—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0228	0.0447	CbGbCtD
Oxybutynin—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0213	0.0418	CbGbCtD
Oxybutynin—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0203	0.0399	CbGbCtD
Oxybutynin—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0186	0.0365	CbGbCtD
Oxybutynin—CYP3A5—Losartan—type 2 diabetes mellitus	0.0177	0.0346	CbGbCtD
Oxybutynin—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0175	0.0344	CbGbCtD
Oxybutynin—CYP2C8—Losartan—type 2 diabetes mellitus	0.017	0.0333	CbGbCtD
Oxybutynin—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0168	0.0329	CbGbCtD
Oxybutynin—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0163	0.0319	CbGbCtD
Oxybutynin—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0147	0.0288	CbGbCtD
Oxybutynin—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0111	0.0218	CbGbCtD
Oxybutynin—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0107	0.0209	CbGbCtD
Oxybutynin—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0107	0.0209	CbGbCtD
Oxybutynin—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0101	0.0198	CbGbCtD
Oxybutynin—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00753	0.0148	CbGbCtD
Oxybutynin—CYP3A4—Losartan—type 2 diabetes mellitus	0.00688	0.0135	CbGbCtD
Oxybutynin—Rash—Sitagliptin—type 2 diabetes mellitus	0.000106	0.000491	CcSEcCtD
Oxybutynin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000106	0.00049	CcSEcCtD
Oxybutynin—Headache—Glimepiride—type 2 diabetes mellitus	0.000106	0.000489	CcSEcCtD
Oxybutynin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000106	0.000488	CcSEcCtD
Oxybutynin—Cough—Irbesartan—type 2 diabetes mellitus	0.000106	0.000488	CcSEcCtD
Oxybutynin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000105	0.000488	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000105	0.000484	CcSEcCtD
Oxybutynin—Agitation—Losartan—type 2 diabetes mellitus	0.000105	0.000484	CcSEcCtD
Oxybutynin—Oedema—Metformin—type 2 diabetes mellitus	0.000105	0.000484	CcSEcCtD
Oxybutynin—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000105	0.000483	CcSEcCtD
Oxybutynin—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000104	0.000483	CcSEcCtD
Oxybutynin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000482	CcSEcCtD
Oxybutynin—Flushing—Ramipril—type 2 diabetes mellitus	0.000104	0.000481	CcSEcCtD
Oxybutynin—Angioedema—Losartan—type 2 diabetes mellitus	0.000104	0.000481	CcSEcCtD
Oxybutynin—Infection—Metformin—type 2 diabetes mellitus	0.000104	0.000481	CcSEcCtD
Oxybutynin—Insomnia—Valsartan—type 2 diabetes mellitus	0.000104	0.00048	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000103	0.000478	CcSEcCtD
Oxybutynin—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000103	0.000477	CcSEcCtD
Oxybutynin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000103	0.000476	CcSEcCtD
Oxybutynin—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000476	CcSEcCtD
Oxybutynin—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000103	0.000476	CcSEcCtD
Oxybutynin—Shock—Metformin—type 2 diabetes mellitus	0.000103	0.000476	CcSEcCtD
Oxybutynin—Insomnia—Orlistat—type 2 diabetes mellitus	0.000103	0.000475	CcSEcCtD
Oxybutynin—Malaise—Losartan—type 2 diabetes mellitus	0.000103	0.000475	CcSEcCtD
Oxybutynin—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000103	0.000475	CcSEcCtD
Oxybutynin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000103	0.000474	CcSEcCtD
Oxybutynin—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000103	0.000474	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000102	0.000473	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000102	0.000473	CcSEcCtD
Oxybutynin—Somnolence—Valsartan—type 2 diabetes mellitus	0.000102	0.000472	CcSEcCtD
Oxybutynin—Syncope—Losartan—type 2 diabetes mellitus	0.000102	0.000472	CcSEcCtD
Oxybutynin—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000102	0.000471	CcSEcCtD
Oxybutynin—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000102	0.000471	CcSEcCtD
Oxybutynin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000102	0.00047	CcSEcCtD
Oxybutynin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000101	0.000468	CcSEcCtD
Oxybutynin—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000101	0.000467	CcSEcCtD
Oxybutynin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000101	0.000466	CcSEcCtD
Oxybutynin—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000101	0.000466	CcSEcCtD
Oxybutynin—Palpitations—Losartan—type 2 diabetes mellitus	0.000101	0.000465	CcSEcCtD
Oxybutynin—Nausea—Glimepiride—type 2 diabetes mellitus	0.0001	0.000464	CcSEcCtD
Oxybutynin—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.0001	0.000463	CcSEcCtD
Oxybutynin—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.0001	0.000463	CcSEcCtD
Oxybutynin—Nausea—Sitagliptin—type 2 diabetes mellitus	9.99e-05	0.000462	CcSEcCtD
Oxybutynin—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.99e-05	0.000462	CcSEcCtD
Oxybutynin—Asthenia—Glyburide—type 2 diabetes mellitus	9.99e-05	0.000462	CcSEcCtD
Oxybutynin—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.98e-05	0.000462	CcSEcCtD
Oxybutynin—Anorexia—Metformin—type 2 diabetes mellitus	9.97e-05	0.000461	CcSEcCtD
Oxybutynin—Cough—Losartan—type 2 diabetes mellitus	9.93e-05	0.000459	CcSEcCtD
Oxybutynin—Urticaria—Gliclazide—type 2 diabetes mellitus	9.93e-05	0.000459	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.92e-05	0.000459	CcSEcCtD
Oxybutynin—Fatigue—Valsartan—type 2 diabetes mellitus	9.9e-05	0.000458	CcSEcCtD
Oxybutynin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.88e-05	0.000457	CcSEcCtD
Oxybutynin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.87e-05	0.000457	CcSEcCtD
Oxybutynin—Oedema—Irbesartan—type 2 diabetes mellitus	9.87e-05	0.000457	CcSEcCtD
Oxybutynin—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.87e-05	0.000456	CcSEcCtD
Oxybutynin—Pruritus—Glyburide—type 2 diabetes mellitus	9.85e-05	0.000456	CcSEcCtD
Oxybutynin—Mental disorder—Ramipril—type 2 diabetes mellitus	9.82e-05	0.000454	CcSEcCtD
Oxybutynin—Constipation—Valsartan—type 2 diabetes mellitus	9.82e-05	0.000454	CcSEcCtD
Oxybutynin—Infection—Irbesartan—type 2 diabetes mellitus	9.81e-05	0.000454	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	9.8e-05	0.000453	CcSEcCtD
Oxybutynin—Fatigue—Orlistat—type 2 diabetes mellitus	9.78e-05	0.000453	CcSEcCtD
Oxybutynin—Hypotension—Metformin—type 2 diabetes mellitus	9.77e-05	0.000452	CcSEcCtD
Oxybutynin—Erythema—Ramipril—type 2 diabetes mellitus	9.76e-05	0.000451	CcSEcCtD
Oxybutynin—Malnutrition—Ramipril—type 2 diabetes mellitus	9.76e-05	0.000451	CcSEcCtD
Oxybutynin—Shock—Irbesartan—type 2 diabetes mellitus	9.71e-05	0.000449	CcSEcCtD
Oxybutynin—Pain—Orlistat—type 2 diabetes mellitus	9.7e-05	0.000449	CcSEcCtD
Oxybutynin—Chest pain—Losartan—type 2 diabetes mellitus	9.69e-05	0.000448	CcSEcCtD
Oxybutynin—Arthralgia—Losartan—type 2 diabetes mellitus	9.69e-05	0.000448	CcSEcCtD
Oxybutynin—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.68e-05	0.000448	CcSEcCtD
Oxybutynin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	9.68e-05	0.000448	CcSEcCtD
Oxybutynin—Anxiety—Losartan—type 2 diabetes mellitus	9.66e-05	0.000447	CcSEcCtD
Oxybutynin—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.63e-05	0.000446	CcSEcCtD
Oxybutynin—Rash—Bromocriptine—type 2 diabetes mellitus	9.6e-05	0.000444	CcSEcCtD
Oxybutynin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.59e-05	0.000444	CcSEcCtD
Oxybutynin—Skin disorder—Irbesartan—type 2 diabetes mellitus	9.59e-05	0.000443	CcSEcCtD
Oxybutynin—Tension—Ramipril—type 2 diabetes mellitus	9.58e-05	0.000443	CcSEcCtD
Oxybutynin—Discomfort—Losartan—type 2 diabetes mellitus	9.57e-05	0.000443	CcSEcCtD
Oxybutynin—Dysgeusia—Ramipril—type 2 diabetes mellitus	9.56e-05	0.000442	CcSEcCtD
Oxybutynin—Headache—Bromocriptine—type 2 diabetes mellitus	9.54e-05	0.000441	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.53e-05	0.000441	CcSEcCtD
Oxybutynin—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.52e-05	0.000441	CcSEcCtD
Oxybutynin—Nervousness—Ramipril—type 2 diabetes mellitus	9.48e-05	0.000438	CcSEcCtD
Oxybutynin—Dry mouth—Losartan—type 2 diabetes mellitus	9.48e-05	0.000438	CcSEcCtD
Oxybutynin—Anorexia—Irbesartan—type 2 diabetes mellitus	9.41e-05	0.000435	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.39e-05	0.000434	CcSEcCtD
Oxybutynin—Paraesthesia—Metformin—type 2 diabetes mellitus	9.39e-05	0.000434	CcSEcCtD
Oxybutynin—Confusional state—Losartan—type 2 diabetes mellitus	9.37e-05	0.000433	CcSEcCtD
Oxybutynin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.35e-05	0.000433	CcSEcCtD
Oxybutynin—Somnolence—Metformin—type 2 diabetes mellitus	9.3e-05	0.00043	CcSEcCtD
Oxybutynin—Oedema—Losartan—type 2 diabetes mellitus	9.29e-05	0.00043	CcSEcCtD
Oxybutynin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	9.29e-05	0.00043	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.28e-05	0.000429	CcSEcCtD
Oxybutynin—Infection—Losartan—type 2 diabetes mellitus	9.23e-05	0.000427	CcSEcCtD
Oxybutynin—Hypotension—Irbesartan—type 2 diabetes mellitus	9.22e-05	0.000427	CcSEcCtD
Oxybutynin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.21e-05	0.000426	CcSEcCtD
Oxybutynin—Dyspepsia—Metformin—type 2 diabetes mellitus	9.21e-05	0.000426	CcSEcCtD
Oxybutynin—Shock—Losartan—type 2 diabetes mellitus	9.14e-05	0.000423	CcSEcCtD
Oxybutynin—Urticaria—Valsartan—type 2 diabetes mellitus	9.12e-05	0.000422	CcSEcCtD
Oxybutynin—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.11e-05	0.000421	CcSEcCtD
Oxybutynin—Decreased appetite—Metformin—type 2 diabetes mellitus	9.09e-05	0.000421	CcSEcCtD
Oxybutynin—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.08e-05	0.00042	CcSEcCtD
Oxybutynin—Tachycardia—Losartan—type 2 diabetes mellitus	9.07e-05	0.000419	CcSEcCtD
Oxybutynin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.05e-05	0.000419	CcSEcCtD
Oxybutynin—Nausea—Bromocriptine—type 2 diabetes mellitus	9.05e-05	0.000418	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.03e-05	0.000418	CcSEcCtD
Oxybutynin—Fatigue—Metformin—type 2 diabetes mellitus	9.02e-05	0.000417	CcSEcCtD
Oxybutynin—Urticaria—Orlistat—type 2 diabetes mellitus	9.02e-05	0.000417	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000416	CcSEcCtD
Oxybutynin—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.97e-05	0.000415	CcSEcCtD
Oxybutynin—Asthenia—Gliclazide—type 2 diabetes mellitus	8.97e-05	0.000415	CcSEcCtD
Oxybutynin—Agitation—Ramipril—type 2 diabetes mellitus	8.97e-05	0.000415	CcSEcCtD
Oxybutynin—Constipation—Metformin—type 2 diabetes mellitus	8.94e-05	0.000414	CcSEcCtD
Oxybutynin—Angioedema—Ramipril—type 2 diabetes mellitus	8.92e-05	0.000412	CcSEcCtD
Oxybutynin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.86e-05	0.00041	CcSEcCtD
Oxybutynin—Anorexia—Losartan—type 2 diabetes mellitus	8.85e-05	0.00041	CcSEcCtD
Oxybutynin—Vomiting—Glyburide—type 2 diabetes mellitus	8.85e-05	0.000409	CcSEcCtD
Oxybutynin—Pruritus—Gliclazide—type 2 diabetes mellitus	8.84e-05	0.000409	CcSEcCtD
Oxybutynin—Malaise—Ramipril—type 2 diabetes mellitus	8.8e-05	0.000407	CcSEcCtD
Oxybutynin—Rash—Glyburide—type 2 diabetes mellitus	8.78e-05	0.000406	CcSEcCtD
Oxybutynin—Somnolence—Irbesartan—type 2 diabetes mellitus	8.77e-05	0.000406	CcSEcCtD
Oxybutynin—Dermatitis—Glyburide—type 2 diabetes mellitus	8.77e-05	0.000406	CcSEcCtD
Oxybutynin—Syncope—Ramipril—type 2 diabetes mellitus	8.75e-05	0.000405	CcSEcCtD
Oxybutynin—Headache—Glyburide—type 2 diabetes mellitus	8.72e-05	0.000403	CcSEcCtD
Oxybutynin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.69e-05	0.000402	CcSEcCtD
Oxybutynin—Hypotension—Losartan—type 2 diabetes mellitus	8.68e-05	0.000401	CcSEcCtD
Oxybutynin—Palpitations—Ramipril—type 2 diabetes mellitus	8.62e-05	0.000399	CcSEcCtD
Oxybutynin—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.62e-05	0.000399	CcSEcCtD
Oxybutynin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.58e-05	0.000397	CcSEcCtD
Oxybutynin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.58e-05	0.000397	CcSEcCtD
Oxybutynin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.55e-05	0.000396	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.55e-05	0.000396	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.52e-05	0.000394	CcSEcCtD
Oxybutynin—Cough—Ramipril—type 2 diabetes mellitus	8.52e-05	0.000394	CcSEcCtD
Oxybutynin—Fatigue—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000394	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.46e-05	0.000391	CcSEcCtD
Oxybutynin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.46e-05	0.000391	CcSEcCtD
Oxybutynin—Convulsion—Ramipril—type 2 diabetes mellitus	8.46e-05	0.000391	CcSEcCtD
Oxybutynin—Pain—Irbesartan—type 2 diabetes mellitus	8.44e-05	0.00039	CcSEcCtD
Oxybutynin—Constipation—Irbesartan—type 2 diabetes mellitus	8.44e-05	0.00039	CcSEcCtD
Oxybutynin—Insomnia—Losartan—type 2 diabetes mellitus	8.4e-05	0.000389	CcSEcCtD
Oxybutynin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.36e-05	0.000387	CcSEcCtD
Oxybutynin—Paraesthesia—Losartan—type 2 diabetes mellitus	8.34e-05	0.000386	CcSEcCtD
Oxybutynin—Urticaria—Metformin—type 2 diabetes mellitus	8.31e-05	0.000384	CcSEcCtD
Oxybutynin—Arthralgia—Ramipril—type 2 diabetes mellitus	8.31e-05	0.000384	CcSEcCtD
Oxybutynin—Chest pain—Ramipril—type 2 diabetes mellitus	8.31e-05	0.000384	CcSEcCtD
Oxybutynin—Anxiety—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000383	CcSEcCtD
Oxybutynin—Nausea—Glyburide—type 2 diabetes mellitus	8.27e-05	0.000382	CcSEcCtD
Oxybutynin—Abdominal pain—Metformin—type 2 diabetes mellitus	8.27e-05	0.000382	CcSEcCtD
Oxybutynin—Dizziness—Gliclazide—type 2 diabetes mellitus	8.27e-05	0.000382	CcSEcCtD
Oxybutynin—Somnolence—Losartan—type 2 diabetes mellitus	8.26e-05	0.000382	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	8.25e-05	0.000382	CcSEcCtD
Oxybutynin—Asthenia—Valsartan—type 2 diabetes mellitus	8.24e-05	0.000381	CcSEcCtD
Oxybutynin—Discomfort—Ramipril—type 2 diabetes mellitus	8.21e-05	0.00038	CcSEcCtD
Oxybutynin—Dyspepsia—Losartan—type 2 diabetes mellitus	8.18e-05	0.000378	CcSEcCtD
Oxybutynin—Asthenia—Orlistat—type 2 diabetes mellitus	8.14e-05	0.000377	CcSEcCtD
Oxybutynin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.13e-05	0.000376	CcSEcCtD
Oxybutynin—Pruritus—Valsartan—type 2 diabetes mellitus	8.13e-05	0.000376	CcSEcCtD
Oxybutynin—Dry mouth—Ramipril—type 2 diabetes mellitus	8.13e-05	0.000376	CcSEcCtD
Oxybutynin—Decreased appetite—Losartan—type 2 diabetes mellitus	8.07e-05	0.000373	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.07e-05	0.000373	CcSEcCtD
Oxybutynin—Confusional state—Ramipril—type 2 diabetes mellitus	8.03e-05	0.000371	CcSEcCtD
Oxybutynin—Pruritus—Orlistat—type 2 diabetes mellitus	8.03e-05	0.000371	CcSEcCtD
Oxybutynin—Fatigue—Losartan—type 2 diabetes mellitus	8.01e-05	0.00037	CcSEcCtD
Oxybutynin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000368	CcSEcCtD
Oxybutynin—Oedema—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000368	CcSEcCtD
Oxybutynin—Vomiting—Gliclazide—type 2 diabetes mellitus	7.95e-05	0.000368	CcSEcCtD
Oxybutynin—Pain—Losartan—type 2 diabetes mellitus	7.94e-05	0.000367	CcSEcCtD
Oxybutynin—Constipation—Losartan—type 2 diabetes mellitus	7.94e-05	0.000367	CcSEcCtD
Oxybutynin—Rash—Gliclazide—type 2 diabetes mellitus	7.88e-05	0.000365	CcSEcCtD
Oxybutynin—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.87e-05	0.000364	CcSEcCtD
Oxybutynin—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.86e-05	0.000363	CcSEcCtD
Oxybutynin—Urticaria—Irbesartan—type 2 diabetes mellitus	7.84e-05	0.000363	CcSEcCtD
Oxybutynin—Shock—Ramipril—type 2 diabetes mellitus	7.84e-05	0.000362	CcSEcCtD
Oxybutynin—Headache—Gliclazide—type 2 diabetes mellitus	7.83e-05	0.000362	CcSEcCtD
Oxybutynin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	7.81e-05	0.000361	CcSEcCtD
Oxybutynin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.8e-05	0.000361	CcSEcCtD
Oxybutynin—Tachycardia—Ramipril—type 2 diabetes mellitus	7.77e-05	0.00036	CcSEcCtD
Oxybutynin—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.76e-05	0.000359	CcSEcCtD
Oxybutynin—Skin disorder—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000358	CcSEcCtD
Oxybutynin—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.65e-05	0.000354	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.6e-05	0.000351	CcSEcCtD
Oxybutynin—Dizziness—Valsartan—type 2 diabetes mellitus	7.59e-05	0.000351	CcSEcCtD
Oxybutynin—Anorexia—Ramipril—type 2 diabetes mellitus	7.59e-05	0.000351	CcSEcCtD
Oxybutynin—Dizziness—Orlistat—type 2 diabetes mellitus	7.5e-05	0.000347	CcSEcCtD
Oxybutynin—Asthenia—Metformin—type 2 diabetes mellitus	7.5e-05	0.000347	CcSEcCtD
Oxybutynin—Hypotension—Ramipril—type 2 diabetes mellitus	7.44e-05	0.000344	CcSEcCtD
Oxybutynin—Nausea—Gliclazide—type 2 diabetes mellitus	7.43e-05	0.000343	CcSEcCtD
Oxybutynin—Pruritus—Metformin—type 2 diabetes mellitus	7.4e-05	0.000342	CcSEcCtD
Oxybutynin—Urticaria—Losartan—type 2 diabetes mellitus	7.38e-05	0.000341	CcSEcCtD
Oxybutynin—Abdominal pain—Losartan—type 2 diabetes mellitus	7.34e-05	0.00034	CcSEcCtD
Oxybutynin—Vomiting—Valsartan—type 2 diabetes mellitus	7.3e-05	0.000338	CcSEcCtD
Oxybutynin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.27e-05	0.000336	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.26e-05	0.000336	CcSEcCtD
Oxybutynin—Rash—Valsartan—type 2 diabetes mellitus	7.24e-05	0.000335	CcSEcCtD
Oxybutynin—Dermatitis—Valsartan—type 2 diabetes mellitus	7.23e-05	0.000335	CcSEcCtD
Oxybutynin—Vomiting—Orlistat—type 2 diabetes mellitus	7.22e-05	0.000334	CcSEcCtD
Oxybutynin—Insomnia—Ramipril—type 2 diabetes mellitus	7.2e-05	0.000333	CcSEcCtD
Oxybutynin—Headache—Valsartan—type 2 diabetes mellitus	7.19e-05	0.000333	CcSEcCtD
Oxybutynin—Diarrhoea—Metformin—type 2 diabetes mellitus	7.16e-05	0.000331	CcSEcCtD
Oxybutynin—Rash—Orlistat—type 2 diabetes mellitus	7.16e-05	0.000331	CcSEcCtD
Oxybutynin—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.15e-05	0.000331	CcSEcCtD
Oxybutynin—Dermatitis—Orlistat—type 2 diabetes mellitus	7.15e-05	0.000331	CcSEcCtD
Oxybutynin—Headache—Orlistat—type 2 diabetes mellitus	7.11e-05	0.000329	CcSEcCtD
Oxybutynin—Asthenia—Irbesartan—type 2 diabetes mellitus	7.08e-05	0.000328	CcSEcCtD
Oxybutynin—Somnolence—Ramipril—type 2 diabetes mellitus	7.08e-05	0.000328	CcSEcCtD
Oxybutynin—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.01e-05	0.000324	CcSEcCtD
Oxybutynin—Pruritus—Irbesartan—type 2 diabetes mellitus	6.98e-05	0.000323	CcSEcCtD
Oxybutynin—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.92e-05	0.00032	CcSEcCtD
Oxybutynin—Dizziness—Metformin—type 2 diabetes mellitus	6.92e-05	0.00032	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.88e-05	0.000318	CcSEcCtD
Oxybutynin—Fatigue—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000318	CcSEcCtD
Oxybutynin—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.84e-05	0.000317	CcSEcCtD
Oxybutynin—Nausea—Valsartan—type 2 diabetes mellitus	6.82e-05	0.000316	CcSEcCtD
Oxybutynin—Constipation—Ramipril—type 2 diabetes mellitus	6.81e-05	0.000315	CcSEcCtD
Oxybutynin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000312	CcSEcCtD
Oxybutynin—Nausea—Orlistat—type 2 diabetes mellitus	6.74e-05	0.000312	CcSEcCtD
Oxybutynin—Asthenia—Losartan—type 2 diabetes mellitus	6.66e-05	0.000308	CcSEcCtD
Oxybutynin—Vomiting—Metformin—type 2 diabetes mellitus	6.65e-05	0.000308	CcSEcCtD
Oxybutynin—Rash—Metformin—type 2 diabetes mellitus	6.59e-05	0.000305	CcSEcCtD
Oxybutynin—Dermatitis—Metformin—type 2 diabetes mellitus	6.59e-05	0.000305	CcSEcCtD
Oxybutynin—Pruritus—Losartan—type 2 diabetes mellitus	6.57e-05	0.000304	CcSEcCtD
Oxybutynin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.56e-05	0.000304	CcSEcCtD
Oxybutynin—Headache—Metformin—type 2 diabetes mellitus	6.55e-05	0.000303	CcSEcCtD
Oxybutynin—Dizziness—Irbesartan—type 2 diabetes mellitus	6.53e-05	0.000302	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000301	CcSEcCtD
Oxybutynin—Diarrhoea—Losartan—type 2 diabetes mellitus	6.36e-05	0.000294	CcSEcCtD
Oxybutynin—Urticaria—Ramipril—type 2 diabetes mellitus	6.33e-05	0.000293	CcSEcCtD
Oxybutynin—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000291	CcSEcCtD
Oxybutynin—Vomiting—Irbesartan—type 2 diabetes mellitus	6.28e-05	0.00029	CcSEcCtD
Oxybutynin—Rash—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000288	CcSEcCtD
Oxybutynin—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000288	CcSEcCtD
Oxybutynin—Nausea—Metformin—type 2 diabetes mellitus	6.21e-05	0.000287	CcSEcCtD
Oxybutynin—Headache—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000286	CcSEcCtD
Oxybutynin—Dizziness—Losartan—type 2 diabetes mellitus	6.14e-05	0.000284	CcSEcCtD
Oxybutynin—Vomiting—Losartan—type 2 diabetes mellitus	5.91e-05	0.000273	CcSEcCtD
Oxybutynin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000271	CcSEcCtD
Oxybutynin—Nausea—Irbesartan—type 2 diabetes mellitus	5.86e-05	0.000271	CcSEcCtD
Oxybutynin—Rash—Losartan—type 2 diabetes mellitus	5.86e-05	0.000271	CcSEcCtD
Oxybutynin—Dermatitis—Losartan—type 2 diabetes mellitus	5.85e-05	0.000271	CcSEcCtD
Oxybutynin—Headache—Losartan—type 2 diabetes mellitus	5.82e-05	0.000269	CcSEcCtD
Oxybutynin—Asthenia—Ramipril—type 2 diabetes mellitus	5.71e-05	0.000264	CcSEcCtD
Oxybutynin—Pruritus—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000261	CcSEcCtD
Oxybutynin—Nausea—Losartan—type 2 diabetes mellitus	5.52e-05	0.000255	CcSEcCtD
Oxybutynin—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000252	CcSEcCtD
Oxybutynin—Dizziness—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000244	CcSEcCtD
Oxybutynin—Vomiting—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000234	CcSEcCtD
Oxybutynin—Rash—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000232	CcSEcCtD
Oxybutynin—Dermatitis—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000232	CcSEcCtD
Oxybutynin—Headache—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000231	CcSEcCtD
Oxybutynin—Nausea—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000219	CcSEcCtD
Oxybutynin—CHRM5—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.81e-06	8.56e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.8e-06	8.55e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	6.79e-06	8.54e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.78e-06	8.52e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.77e-06	8.52e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	6.77e-06	8.51e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.75e-06	8.49e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.69e-06	8.41e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.65e-06	8.37e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.65e-06	8.37e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.65e-06	8.37e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.65e-06	8.37e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	6.63e-06	8.34e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.6e-06	8.3e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	6.6e-06	8.3e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	6.59e-06	8.29e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	6.57e-06	8.26e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	6.56e-06	8.25e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	6.56e-06	8.25e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	6.51e-06	8.18e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.49e-06	8.16e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	6.48e-06	8.15e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.47e-06	8.14e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.46e-06	8.13e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.41e-06	8.06e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	6.39e-06	8.04e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.38e-06	8.02e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.38e-06	8.02e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.36e-06	7.99e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.29e-06	7.91e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	6.29e-06	7.91e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	6.29e-06	7.9e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	6.29e-06	7.9e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	6.25e-06	7.85e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	6.23e-06	7.84e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	6.21e-06	7.81e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.17e-06	7.76e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.17e-06	7.76e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	6.15e-06	7.73e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	6.13e-06	7.71e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	6.12e-06	7.7e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	6.02e-06	7.57e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	6.01e-06	7.56e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.94e-06	7.47e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	5.93e-06	7.46e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.93e-06	7.46e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.93e-06	7.45e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.92e-06	7.45e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.92e-06	7.44e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.91e-06	7.43e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—INS—type 2 diabetes mellitus	5.91e-06	7.43e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	5.9e-06	7.42e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	5.88e-06	7.4e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.87e-06	7.38e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	5.86e-06	7.37e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.85e-06	7.36e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	5.84e-06	7.35e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	5.84e-06	7.34e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.82e-06	7.32e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	5.82e-06	7.31e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—RELA—type 2 diabetes mellitus	5.81e-06	7.31e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.8e-06	7.3e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.8e-06	7.29e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.8e-06	7.29e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	5.78e-06	7.27e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	5.78e-06	7.27e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	5.75e-06	7.23e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.75e-06	7.23e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.73e-06	7.21e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	5.73e-06	7.2e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	5.73e-06	7.2e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.72e-06	7.19e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	5.71e-06	7.18e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.66e-06	7.12e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	5.64e-06	7.09e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.54e-06	6.96e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.47e-06	6.88e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.45e-06	6.86e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.42e-06	6.82e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.42e-06	6.82e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	5.42e-06	6.81e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.42e-06	6.81e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	5.42e-06	6.81e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	5.41e-06	6.8e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.4e-06	6.79e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	5.39e-06	6.78e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	5.32e-06	6.69e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.32e-06	6.69e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	5.31e-06	6.67e-05	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.29e-06	6.65e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.29e-06	6.65e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.29e-06	6.65e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.29e-06	6.65e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.25e-06	6.6e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.24e-06	6.59e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.21e-06	6.55e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	5.18e-06	6.51e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	5.18e-06	6.51e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.17e-06	6.51e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	5.17e-06	6.5e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.16e-06	6.49e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.16e-06	6.49e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	5.14e-06	6.46e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.11e-06	6.42e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.1e-06	6.41e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	5.07e-06	6.37e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	5.05e-06	6.36e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	5.04e-06	6.33e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	5.03e-06	6.32e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	4.98e-06	6.26e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	4.97e-06	6.25e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	4.96e-06	6.23e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.95e-06	6.23e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	4.94e-06	6.21e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.93e-06	6.2e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.9e-06	6.16e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	4.89e-06	6.15e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.88e-06	6.13e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.86e-06	6.11e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.83e-06	6.07e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.81e-06	6.05e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.81e-06	6.05e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.8e-06	6.04e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.79e-06	6.03e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.79e-06	6.02e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.78e-06	6.01e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.77e-06	6e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.77e-06	6e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.75e-06	5.98e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.74e-06	5.96e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.74e-06	5.96e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.74e-06	5.96e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	4.74e-06	5.96e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.73e-06	5.95e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.73e-06	5.95e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.71e-06	5.92e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	4.69e-06	5.89e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.65e-06	5.85e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.63e-06	5.82e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.61e-06	5.8e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—SRC—type 2 diabetes mellitus	4.57e-06	5.74e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	4.55e-06	5.73e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.55e-06	5.72e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.54e-06	5.71e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.51e-06	5.67e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.49e-06	5.65e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.45e-06	5.59e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	4.44e-06	5.58e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	4.39e-06	5.52e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	4.36e-06	5.48e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	4.36e-06	5.48e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	4.36e-06	5.48e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.35e-06	5.46e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.35e-06	5.46e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.34e-06	5.45e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.33e-06	5.45e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.33e-06	5.45e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	4.3e-06	5.41e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.29e-06	5.39e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.29e-06	5.39e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.29e-06	5.39e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.29e-06	5.39e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	4.22e-06	5.31e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	4.15e-06	5.22e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	4.13e-06	5.2e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.11e-06	5.17e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.11e-06	5.17e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.09e-06	5.14e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	4.09e-06	5.14e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.08e-06	5.13e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	4.08e-06	5.13e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	4.04e-06	5.08e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	4e-06	5.03e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	3.98e-06	5.01e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	3.94e-06	4.96e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	3.77e-06	4.74e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	3.77e-06	4.74e-05	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.72e-06	4.68e-05	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.71e-06	4.67e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.69e-06	4.64e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.68e-06	4.62e-05	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.68e-06	4.62e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.67e-06	4.61e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.65e-06	4.59e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.64e-06	4.58e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.62e-06	4.55e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.6e-06	4.53e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.54e-06	4.45e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.54e-06	4.45e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.53e-06	4.44e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.53e-06	4.43e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.49e-06	4.38e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.48e-06	4.38e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.48e-06	4.37e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	3.45e-06	4.34e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.45e-06	4.34e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.44e-06	4.33e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.44e-06	4.32e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.41e-06	4.28e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.38e-06	4.25e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.38e-06	4.25e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.37e-06	4.24e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.34e-06	4.2e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.29e-06	4.13e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	3.24e-06	4.07e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.23e-06	4.06e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.21e-06	4.04e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	3.2e-06	4.03e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.17e-06	3.99e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.16e-06	3.97e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.15e-06	3.96e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.13e-06	3.94e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.12e-06	3.92e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.1e-06	3.9e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.1e-06	3.9e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.09e-06	3.89e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	3.08e-06	3.87e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.06e-06	3.85e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.03e-06	3.81e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.9e-06	3.65e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.87e-06	3.61e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.86e-06	3.6e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.85e-06	3.58e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.84e-06	3.57e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.84e-06	3.57e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.83e-06	3.56e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.82e-06	3.54e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.81e-06	3.53e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.78e-06	3.5e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.76e-06	3.47e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.71e-06	3.41e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.7e-06	3.4e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.67e-06	3.36e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	2.38e-06	2.99e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.35e-06	2.96e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.31e-06	2.9e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.17e-06	2.72e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.16e-06	2.71e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.14e-06	2.69e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.12e-06	2.66e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.03e-06	2.55e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.03e-06	2.55e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	2e-06	2.52e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2e-06	2.51e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.99e-06	2.5e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.97e-06	2.48e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.85e-06	2.33e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.73e-06	2.18e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.42e-06	1.79e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	9.31e-07	1.17e-05	CbGpPWpGaD
